The historical rank and industry rank for Astec Lifesciences's Net Margin % or its related term are showing as below:
NSE:ASTEC'
s Net Margin % Range Over the Past 10 Years
Min: -35.34 Med: 7.39 Max: 13.28
Current: -18.06
NSE:ASTEC's Net Margin % is ranked worse than 89.2% of 250
companies
in the Agriculture industry
Industry Median: 4.12
vs NSE:ASTEC: -18.06
Astec Lifesciences (NSE:ASTEC) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Astec Lifesciences Net Margin % Related Terms
Astec Lifesciences Net Margin % Historical Data
* Premium members only.
The historical data trend for Astec Lifesciences's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Astec Lifesciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astec Lifesciences Net Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Astec Lifesciences's Net Margin % distribution charts can be found below:
* The bar in red indicates where Astec Lifesciences's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astec Lifesciences (NSE:ASTEC) has a Net Margin % of -4.89% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Astec Lifesciences and its competitors. According to the industry distribution chart, Astec Lifesciences ranks #223 out of 250 companies in the Agriculture industry, placing it in the top 89.2%.
Is Astec Lifesciences' Net Margin % too high?
Astec Lifesciences' current Net Margin % is -4.89%. Based on the distribution chart, Astec Lifesciences ranks #223 out of 250 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Astec Lifesciences has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' Net Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Astec Lifesciences ranks #223 out of 250 companies for Net Margin %. This places Astec Lifesciences in the lower half of its industry. The industry median Net Margin % is 4.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for an Agriculture company?
The median Net Margin % among Agriculture companies is 4.12, based on 250 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Astec Lifesciences and its competitors. For the Agriculture industry, the median Net Margin % is 4.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astec Lifesciences's current Net Margin % is -4.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹976.08, compared to a current price of ₹725.45 — trading 25.7% below its estimated fair value. The current Net Margin % is -4.89%. Astec Lifesciences' overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current Net Margin % is -4.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?
Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued.
The current stock price of ₹725.45 is trading 25.7% below its estimated GF Value™ of ₹976.08.
GuruFocus considers Astec Lifesciences to be Modestly Undervalued.
Key valuation signals for NSE:ASTEC:
Net Margin %: -4.89%
GF Value™: ₹976.08 vs. price of ₹725.45 (25.7% below fair value)
No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
75GF Score
Get the complete analysis for NSE:ASTEC
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ASTEC has been successfully added to your 
